WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Dr. Swapan Kumar Mallick*, Dr. Arup Chakraborty, Dr. Arista Lahiri, Dr. Md Asifullah, Dr. Rajiv Lochan Jena and Dr. Madhumay Pal

ABSTRACT

Introduction: In breast cancer, hormonal status plays a very pivotal role in its etiology, prognosis and treatment in adjuvant as well as metastatic setting. This study explored hormonal profiles of the patients and metastasis in breast cancer. Materials & Methods: Breast cancer patient data were analysed retrospectively from institutional records during the study period from 1st January 2013 to 31st December 2017. The collected data was compiled into EpiInfo 7 software and subsequently analysis of data was done using SPSS software, version 16 and results are mentioned with the help of tables. Result and Discussion: Most of the breast cancer patients were of the age 40-60 years. Most of the patients had locally advanced carcinoma, 49.2%. Hormonal status was known for 82.2% of the patients. In our study ER positive, PR positive & Her-2 positive were 38.4%, 41.09% & 36.9% respectively of the whole sample and 46.67%, 50% & 45% respectively among the hormonal status known patients. Those who received hormonal therapy, were 31.5% amongst all the available records. Patients with HER2, ER & PR status positive (21.67%) and HER2 negative, but positive for ER & PR (16.67%) received hormonal therapy. While 23.33% patients did not receive hormonal therapy, being negative for HER2, ER & PR; it was also observed that 21.67% patients were not given any hormonal therapy, being ER & PR negative but HER2 positive. Conclusion: ER/PR positive was the most frequently observed hormonal profile in our population and this population is eligible for hormonal therapy.